Table 1.

Characteristics of patients with FA in the NAS and SLH cohorts




NAS

SLH

P
No. of cases   145   117   NA  
Person-years of follow-up, total   1983   508   NA  
Male-to-female ratio   76:69   56:61   .54  
Year of birth, (interquartile range*)   1985 (1980-1990)   1981 (1974-1987)   .003  
Median age, y at SCT (interquartile range)   8.9 (5.7-12.7)  10.8 (7.4-13.5)   .048  
Total deaths prior to SCC   21   48   NA  
Total SCC number§  7   11   NA  
Ages at onset of SCC, y   23, 27, 28, 33, 33, 44, 44   10, 16, 17, 17, 18, 19, 22, 23, 24, 28, 33   .004  
Time from transplantation to onset of SCC, y
 
NA
 
5.5, 5.7, 7.5, 8.4, 7.0, 12.4, 9.5, 9.4, 13.8, 21.8, 14.4
 
NA
 



NAS

SLH

P
No. of cases   145   117   NA  
Person-years of follow-up, total   1983   508   NA  
Male-to-female ratio   76:69   56:61   .54  
Year of birth, (interquartile range*)   1985 (1980-1990)   1981 (1974-1987)   .003  
Median age, y at SCT (interquartile range)   8.9 (5.7-12.7)  10.8 (7.4-13.5)   .048  
Total deaths prior to SCC   21   48   NA  
Total SCC number§  7   11   NA  
Ages at onset of SCC, y   23, 27, 28, 33, 33, 44, 44   10, 16, 17, 17, 18, 19, 22, 23, 24, 28, 33   .004  
Time from transplantation to onset of SCC, y
 
NA
 
5.5, 5.7, 7.5, 8.4, 7.0, 12.4, 9.5, 9.4, 13.8, 21.8, 14.4
 
NA
 

NA indicates not applicable.

*

The interquartile range includes the middle 50% of the data.

P value from Fisher exact test (male-to-female ratio) or Wilcoxon test (other contrasts).

Fifty subjects in NAS had a stem cell transplant (BMT); these subjects were not followed beyond BMT in this analysis.

§

These tumors (all head and neck cancers) arose before BMT in NAS and after BMT in SLH.

or Create an Account

Close Modal
Close Modal